Print this article
- 12/15/2023

INDENA: NEW CLINICAL EVIDENCES CONFIRM BETTER MUSCLE UPTAKE IN INDIVIDUALS AFTER SUPPLEMENTATION WITH COENZYME Q10 PHYTOSOME

AgroFOOD Industry Hi Tech

Tags:

A recently issued, new ex-vivo study demonstrates that CoQ10 Phytosome™, i.e. Indena’s UBIQSOME®, optimizes cellular ubiquinone uptake in muscle cells in comparison to unformulated CoQ101. Those evidences confirm the uniqueness of muscle uptake with UBIQSOME® supplementation, already shown by a previous study2.

Moreover, for the first time in CoQ10 formulations, UBIQSOME® resulted in scientific evidence of amelioration of CoQ10 muscle absorption after oral administration, being the only product on the market succeeding in enhancing both plasmatic and muscle CoQ10 levels.

COENZYME Q10 ORAL SUPPLEMENTATION HAS POINTS OF STRENGTH AND WEAKNESS: INDENA’S UBIQSOME® EMPOWERS IT, THANKS TO PHYTOSOME™ MULTI-TALENTED TECHNOLOGY PLATFORM

Coenzyme Q10 plays a central role in generation and regulation of cell bioenergy, being involved in transferring of electrons within the mitochondrial oxidative respiratory chain and hence, ATP production, and has reported to have antioxidant and beneficial effects in improving human health and well-being. On the other hand, CoQ10 has a low oral bioavailability, due to its poor water solubility, high molecular weight, low solubility in lipids and low intestinal permeability.

UBIQSOME® is the innovative food grade delivery system of coenzyme Q10 formulated with the proprietary Multi-Talented Technology Platform developed by Indena. It’s Phytosome™, the breakthrough 10

Thanks to its Phytosome™ formulation, UBIQSOME® is a food-grade highly bioavailable form, standardized in coenzyme Q10 (18-2

THE LAST CLINICAL EVIDENCES SHOW THE CAPACITY OF UBIQSOME® TO REACH THE RIGHT BIOLOGICAL TARGET

The most recent human study1 on CoQ10 Phytosome™ involved, using a crossover design, eight volunteers randomized to supplement 100 mg/daily CoQ10 for two weeks, delivered both in Phytosome™ form and in CoQ10 crystalline form. After supplementation, plasma was collected, and low-density lipoproteins (LDL) were extracted, normalized for CoQ10 content, and incubated with two different cell lines for 24 h.

The in-vitro results show that UBQ-enriched lipoproteins showed a higher bioavailability compared with crystalline CoQ10-enriched ones in both dermal fibroblasts and myoblasts. Those data suggest that Phytosome™ carriers might provide a specific advantage in delivering CoQ10 to skin and muscle tissues.

“We’re happy and proud of these new results from the study led by professor Tiano, which confirm that our UBIQSOME® is a great formulation of coenzyme Q10 – says Serena Tongiani, Chief Product Officer at Indena -. They are added to the scientific data build for our product, starting from the multiple evidences which show enhanced plasmatic levels of coenzyme Q10 thanks to UBIQSOME®. Moreover, this studies demonstrated for the first time in humans that UBIQSOME® optimize muscles levels of CoQ10 after oral supplementation compared to baseline. Last but not least, UBIQSOME® has been recently demonstrated to enhance endothelial function already after the first dose in young healthy subjects, showing itself as an effective support to cardiovascular health and healthy ageing even in absence of any specific disease.

All the evidences we got in the last years, including the last ones recently issued, allow us to say that UBIQSOME® – CoQ10 Phytosome™ – is a reliable and promising ingredient for all traditional applications of CoQ10”.

HOW UBIQSOME® ACTUALLY WORKS? Another in-vitro study3 has been made to investigate the mechanism of muscle absorption. Scientific evidences proved that macropinocytosis may underly the cellular internalization of UBIQSOME® in both intestinal and cardiac cells, mainly thanks to its Phytosome™ formulation. Indeed, lecithin matrix proper of Phytosome™ structure allows a higher internalization of Coenzyme Q10 compared with CoQ10 alone. Such evidences show that UBIQSOME® and the lecithin vehicle significantly increased the number of intracellular lipid droplets, especially in cardiac cells, suggesting that both CoQ10 and lipids from Phytosome™ can be internalized as lipid aggregates.

Data showed that UBIQSOME® increased CoQ10 in cell but also within mitochondria, leading to improved oxygen consumption, higher ATP and cell proteins production, higher mitochondria biogenesis and reduced oxidative stress. Thanks to Phytosome™ delivery system, UBIQSOME® can make the difference in delivering CoQ10 within both muscle cell and mitochondria compared with traditional CoQ10 ingredients.

INDENA: SUSTAINABLE PRODUCTION AS A PART OF GLOBAL GOVERNANCE SUSTAINABILITY-ORIENTED

Sustainability has been an approach to governance for Indena for many years. The company makes a major commitment to protect nature, a source of inspiration but also of business, in innovating technology to address climate change and in taking care of people as the real source of sustainable success.

There are five main global sustainability challenges that Indena constantly addresses, to guide its vision and plans: climate change, loss of biodiversity, waste, social vulnerability and health.

Moreover, UBIQSOME® is produced in Indena’s main plant at Settala near Milan, which is run according to sustainability principles, starting from an efficient energy management. In fact, Indena is equipping all its European sites with state-of-the-art photovoltaic panels. The total renewable energy self-production by 2024 will be of 5,013, 000 kwhours per year, equivalent to 2,340 Tons of CO2. saved. In 2024, 6

www.indena.com